Literature DB >> 16117716

The Breathmobile Program: structure, implementation, and evolution of a large-scale, urban, pediatric asthma disease management program.

Craig A Jones1, Loran T Clement, Jean Hanley-Lopez, Tricia Morphew, Kenny Yat Choi Kwong, Francene Lifson, Lawrence Opas, Jeffrey J Guterman.   

Abstract

Despite more than a decade of education and research-oriented intervention programs, inner city children with asthma continue to engage in episodic "rescue" patterns of healthcare and experience a disproportionate level of morbidity. The aim of this study was to establish and evaluate a sustainable community-wide pediatric asthma disease management program designed to shift inner city children in Los Angeles from acute episodic care to regular preventive care in accordance with national standards. In 1995 the Southern California Chapter of the Asthma and Allergy Foundation of America (AAFA), the Los Angeles County Department of Health Services (LAC DHS), and the Los Angeles Unified School District (LAUSD) established an agreement to initiate and sustain the Breathmobile Program. This program includes automated case identification, mobile school-based clinics, and highly structured clinical encounters supported by an advanced information technology solution. Interdisciplinary teams of asthma care specialists provide regular and ongoing care to children at school and county clinic sites over a wide geographic area of urban Los Angeles. Each team operates in a specially equipped mobile clinic (Breathmobile), efficiently moving a structured healthcare process to school and county clinic sites with large numbers of children. Demographic, clinical, and participation data is tracked carefully in an electronic medical record system. Program operations, clinical oversight, and patient tracking are centralized at a care coordination center. Clinical operations and methods have been replicated in fixed specialty clinic sites at the Los Angeles County + University of Southern California Medical Center. Clinical and process measures are regularly evaluated to assure quality, plan iterative improvement, and support evidence-based care. Four Breathmobiles deliver ongoing care at more than 90 school sites. The program has engaged over five thousand patients and their families in a continuity care model that has demonstrated efficacy over usual episodic care. More than 90% of patients in all asthma severity categories achieved clinical control of asthma with significant reductions in inpatient (IP) and emergency department (ED) use. On February 14, 2002, the program became the first program in the United States to receive the award of disease-specific care certification by the Joint Commission on Accreditation of Healthcare Organizations (JCAHO). Proper design and resource allocation can sustain a school-based community-wide pediatric asthma disease management program and shift a population of inner city children from acute episodic care to routine preventive care in accordance with national standards. An evidence-based approach to evaluating and maintaining quality, coupled with stratified care delivery, can assure the efficient use of safety net healthcare resources.

Entities:  

Mesh:

Year:  2005        PMID: 16117716     DOI: 10.1089/dis.2005.8.205

Source DB:  PubMed          Journal:  Dis Manag        ISSN: 1093-507X


  10 in total

Review 1.  Self-management strategies to reduce pain and improve function among older adults in community settings: a review of the evidence.

Authors:  M Carrington Reid; Maria Papaleontiou; Anthony Ong; Risa Breckman; Elaine Wethington; Karl Pillemer
Journal:  Pain Med       Date:  2008-03-11       Impact factor: 3.750

2.  Monitoring asthma control using claims data and patient-reported outcomes measures.

Authors:  Tom James; Michael Fine
Journal:  P T       Date:  2008-08

3.  Challenges in providing preventive care to inner-city children with asthma.

Authors:  Arlene M Butz; Joan Kub; Melissa H Bellin; Kevin D Frick
Journal:  Nurs Clin North Am       Date:  2013-02-15       Impact factor: 1.208

4.  The relationship of the bronchodilator response phenotype to poor asthma control in children with normal spirometry.

Authors:  Stanley P Galant; Tricia Morphew; Robert L Newcomb; Kiem Hioe; Olga Guijon; Otto Liao
Journal:  J Pediatr       Date:  2011-01-13       Impact factor: 4.406

5.  Asthma in Head Start children: effects of the Breathmobile program and family communication on asthma outcomes.

Authors:  Michelle N Eakin; Cynthia S Rand; Andrew Bilderback; Mary E Bollinger; Arlene Butz; Veni Kandasamy; Kristin A Riekert
Journal:  J Allergy Clin Immunol       Date:  2011-11-21       Impact factor: 10.793

6.  Participatory adaptation of an evidence-based, arthritis self-management program: making changes to improve program fit.

Authors:  Samantha J Parker; Emily K Chen; Karl Pillemer; David Filiberto; Evelyn Laureano; Josie Piper; Julia Schwartz-Leeper; Laura Robbins; M Cary Reid
Journal:  Fam Community Health       Date:  2012 Jul-Sep

7.  Using information technology to reduce asthma disparities in underserved populations: a pilot study.

Authors:  Perla A Vargas; Elias Robles; Judith Harris; Peggy Radford
Journal:  J Asthma       Date:  2010-10       Impact factor: 2.515

8.  Residential Proximity to Freeways is Associated with Uncontrolled Asthma in Inner-City Hispanic Children and Adolescents.

Authors:  Peter Huynh; Muhammad T Salam; Tricia Morphew; Kenny Y C Kwong; Lyne Scott
Journal:  J Allergy (Cairo)       Date:  2010-06-13

9.  School-based self-management interventions for asthma in children and adolescents: a mixed methods systematic review.

Authors:  Katherine Harris; Dylan Kneale; Toby J Lasserson; Vanessa M McDonald; Jonathan Grigg; James Thomas
Journal:  Cochrane Database Syst Rev       Date:  2019-01-28

10.  Calculating the return on investment of mobile healthcare.

Authors:  Nancy E Oriol; Paul J Cote; Anthony P Vavasis; Jennifer Bennet; Darien Delorenzo; Philip Blanc; Isaac Kohane
Journal:  BMC Med       Date:  2009-06-02       Impact factor: 8.775

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.